15 results found.

Persistent Atrial Fibrillation Clinical Trial using Convergent Procedure EPi-Sense-AF Guided Coagulation System; Endocardial Catheter Ablation

nContact Surgical Inc. - Recruiting 18 years to 80 years.
- Convergence Of Epicardial And Endocardial Radiofrequency (RF) Ablation For The Treatment Of Symptomatic Persistent AF.
Convergent Procedure EPi-Sense-AF Guided Coagulation System; Endocardial Catheter Ablation

Persistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation, H Clinical Trial using Renal Artery Ablation Catheter; Cardiac Ablation

St. Jude Medical - Recruiting 18 years or older.
- A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and Cardiac Ablation on AF Recurrence.
Renal Artery Ablation Catheter; Cardiac Ablation

Persistent Atrial Fibrillation Clinical Trial using HeartLight(TM) Laser Balloon; irrigated radiofrequency current ablation

Cardioangiologisches Centrum Bethanien - Recruiting 18 years to 80 years.
- Catheter Ablation of Drug-refractory Persistent Atrial Fibrillation With the HeartLight(TM) Laser Balloon in Comparison With Irrigated Radiofrequency Current Ablation.
HeartLight(TM) Laser Balloon; irrigated radiofrequency current ablation

Persistent Atrial Fibrillation, or Longstanding Persistent Atrial Clinical Trial using Synergy Ablation System

AtriCure, Inc. - Recruiting 18 years or older.
- AtriCure Synergy Ablation Lesions for Non-Paroxysmal Forms of Atrial Fibrillation Treatment During Concomitant On-Pump Endo/Epicardial Cardiac Surgery.
Synergy Ablation System

Atrial Fibrillation Clinical Trial using Canakinumab; Placebo

University Hospital, Basel, Switzerland - Recruiting 50 years or older.
- Canakinumab for the Prevention of Recurrences After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation (CONVERT-AF) Trial - A Randomized Double Blind Placebo Controlled Study.
Canakinumab; Placebo

Atrial Fibrillation Clinical Trial using maze procedure; mitral valve surgery; left atrial reduction

Meshalkin Research Institute of Pathology of Circulation - Recruiting 18 years to 65 years.
- Left Atrium Reduction Versus no Left Atrium Reduction for Patients With Enlarged Left Atria and Persistent or Long Standing Persistent Atrial Fibrillation Undergoing Mitral Valve Surgery.
maze procedure; mitral valve surgery; left atrial reduction

Atrial Fibrillation Clinical Trial using 1g of F373280; Placebo

Pierre Fabre Medicament - Recruiting 18 years or older.
- Efficacy and Safety Study of F373280 for Maintenance of Sinus Rhythm After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation and Chronic Heart Failure. International, Multicentric, Randomised, Double-blind, Placebo Controlled Study..
1g of F373280; Placebo

Atrial Fibrillation, Paroxysmal Atrial Fibrillation, or Persisten Clinical Trial using OPC-108459; Placebo

Otsuka Pharmaceutical Development & Commercialization, Inc. - Recruiting 18 years to 85 years.
- A Multi-center, Parallel-group, Double-blind, Placebo-controlled, Randomized, Ascending Dose Trial to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects With Paroxysmal and Persistent Atrial Fibrillation.
OPC-108459; Placebo

Atrial Fibrillation Clinical Trial using Pulmonary Vein Isolation procedure

University of Pennsylvania - Recruiting 18 years or older.
- Second Randomization Study to Assess Efficacy of Different Ablation Strategies in Achieving Long-Term Arrhythmia Control in Patients With Persistent or Long Standing Persistent Atrial Fibrillation: RASTA XT Study.
Pulmonary Vein Isolation procedure

Persistent Atrial Fibrillation Clinical Trial using Medtronic Phased RF Ablation System

Medtronic Atrial Fibrillation Solutions - Recruiting 18 years to 70 years.
- Evaluation of Multielectrode Phased RF Technology in Persistent Atrial Fibrillation.
Medtronic Phased RF Ablation System

Ventricular Tachycardia, or Atrial Fibrillation Clinical Trial using Ethanol; Ablation

The Methodist Hospital System - Recruiting 18 years to 85 years.
- Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation.
Ethanol; Ablation

Atrial Fibrillation, Mitral Valve Insufficiency, or Mitral Valve Clinical Trial using Mitral valve surgery with ligation/excision of left atrial appendage with ablation; Mitral valve surgery with ligation/excision of left atrial appendage

Mount Sinai School of Medicine - Recruiting 18 years or older.
- Surgical Ablation Versus No Surgical Ablation for Patients With Persistent or Longstanding Persistent Atrial Fibrillation (AF) Undergoing Mitral Valve Surgery.
Mitral valve surgery with ligation/excision of left atrial appendage with ablation; Mitral valve surgery with ligation/excision of left atrial appendage

Atrial Fibrillation Clinical Trial using Ranolazine; Matching placebo

University of Oklahoma - Recruiting 21 years or older.
- Ranolazine for the Prevention of Recurrent Persistent Atrial Fibrillation After Electrical Cardioversion: a Pilot Study.
Ranolazine; Matching placebo

Atrial Fibrillation, or Heart Failure Clinical Trial using Catheter ablation of persistent atrial fibrillation; Medical treatment alone

Barts & The London NHS Trust - Recruiting 18 years or older.
- Catheter Ablation Versus Medical Treatment of AF in Heart Failure.
Catheter ablation of persistent atrial fibrillation; Medical treatment alone

Atrial Fibrillation, or Tachycardia Clinical Trial using pulmonary vein isolation; pulmonary vein isolation with additional ablation of fragmented potentials

Asklepios proresearch - Recruiting 18 years to 75 years.
- Ablation at St. Georg Hospital for Long-Standing Persistent Atrial Fibrillation - Pulmonary Vein Isolation With or Without Ablation of Complex Fragmented Atrial Potentials.
pulmonary vein isolation; pulmonary vein isolation with additional ablation of fragmented potentials